Delayed
Other stock markets
|
5-day change | 1st Jan Change | ||
6.28 USD | +1.62% |
|
-7.24% | +25.10% |
06-20 | Sector Update: Health Care Stocks Mixed Thursday Afternoon | MT |
06-20 | ImmunityBio Shares Rise After Launch of Bladder Cancer Treatment Anktiva in US | MT |
This article is reserved for members
Already a member?
Log InNot a member ?
Free registration![Consensus](/images/consensus_flch.gif)
EPS Revisions
1st Jan change | Capi. | |
---|---|---|
+25.10% | 4.34B | |
+15.58% | 121B | |
+16.60% | 110B | |
+17.73% | 25.93B | |
-24.33% | 19.27B | |
-19.35% | 16.01B | |
-17.95% | 15.66B | |
-48.32% | 14.89B | |
+58.78% | 14.47B | |
+4.91% | 13.91B |
- Stock Market
- Equities
- IBRX Stock
- News ImmunityBio, Inc.
- ImmunityBio Enrolls First Subjects in Lung Cancer Master Protocol Trial of Anktiva